The Issue on Dualistic Role of Neutrophils in Carcinogenesis and Their Possible Use for Treatment of Malignant Neoplasms
Neutrophils are phagocytic leukocytes of the myeloid series, which are the most common myeloid cells in human blood, normally accounting from 65 to 80% of all circulating leukocytes. Over the years of investigation of these cells, more and more evidence has emerged indicating functional plasticity o...
Saved in:
| Published in | Biochemistry (Moscow) Vol. 90; no. 3; pp. 303 - 320 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
Moscow
Pleiades Publishing
01.03.2025
Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0006-2979 1608-3040 1608-3040 |
| DOI | 10.1134/S000629792460368X |
Cover
Loading…
| Abstract | Neutrophils are phagocytic leukocytes of the myeloid series, which are the most common myeloid cells in human blood, normally accounting from 65 to 80% of all circulating leukocytes. Over the years of investigation of these cells, more and more evidence has emerged indicating functional plasticity of neutrophils and their ambiguous role in the tumor development. Similarly to the M1/M2 classification of macrophages, the N1/N2 paradigm could be applied to neutrophils, where N1-neutrophils exhibit tumor-suppressive properties, and N2-neutrophils contribute to tumor development and immune suppression. An important natural feature of neutrophils is their mobility and ability to overcome physical barriers, thus these cells, as well as their vesicles and membranes, could be used to deliver therapeutic drugs to tumor cells. In addition, neutrophils themselves could be activated and mobilized to fight the tumor. This review describes current state of research on the role of neutrophils in carcinogenesis, as well as possible approaches of using these cells and their derivatives as systems for targeted delivery of therapeutic drugs for treatment of malignant neoplasms. |
|---|---|
| AbstractList | Neutrophils are phagocytic leukocytes of the myeloid series, which are the most common myeloid cells in human blood, normally accounting from 65 to 80% of all circulating leukocytes. Over the years of investigation of these cells, more and more evidence has emerged indicating functional plasticity of neutrophils and their ambiguous role in the tumor development. Similarly to the M1/M2 classification of macrophages, the N1/N2 paradigm could be applied to neutrophils, where N1-neutrophils exhibit tumor-suppressive properties, and N2-neutrophils contribute to tumor development and immune suppression. An important natural feature of neutrophils is their mobility and ability to overcome physical barriers, thus these cells, as well as their vesicles and membranes, could be used to deliver therapeutic drugs to tumor cells. In addition, neutrophils themselves could be activated and mobilized to fight the tumor. This review describes current state of research on the role of neutrophils in carcinogenesis, as well as possible approaches of using these cells and their derivatives as systems for targeted delivery of therapeutic drugs for treatment of malignant neoplasms. Neutrophils are phagocytic leukocytes of the myeloid series, which are the most common myeloid cells in human blood, normally accounting from 65 to 80% of all circulating leukocytes. Over the years of investigation of these cells, more and more evidence has emerged indicating functional plasticity of neutrophils and their ambiguous role in the tumor development. Similarly to the M1/M2 classification of macrophages, the N1/N2 paradigm could be applied to neutrophils, where N1-neutrophils exhibit tumor-suppressive properties, and N2-neutrophils contribute to tumor development and immune suppression. An important natural feature of neutrophils is their mobility and ability to overcome physical barriers, thus these cells, as well as their vesicles and membranes, could be used to deliver therapeutic drugs to tumor cells. In addition, neutrophils themselves could be activated and mobilized to fight the tumor. This review describes current state of research on the role of neutrophils in carcinogenesis, as well as possible approaches of using these cells and their derivatives as systems for targeted delivery of therapeutic drugs for treatment of malignant neoplasms.Neutrophils are phagocytic leukocytes of the myeloid series, which are the most common myeloid cells in human blood, normally accounting from 65 to 80% of all circulating leukocytes. Over the years of investigation of these cells, more and more evidence has emerged indicating functional plasticity of neutrophils and their ambiguous role in the tumor development. Similarly to the M1/M2 classification of macrophages, the N1/N2 paradigm could be applied to neutrophils, where N1-neutrophils exhibit tumor-suppressive properties, and N2-neutrophils contribute to tumor development and immune suppression. An important natural feature of neutrophils is their mobility and ability to overcome physical barriers, thus these cells, as well as their vesicles and membranes, could be used to deliver therapeutic drugs to tumor cells. In addition, neutrophils themselves could be activated and mobilized to fight the tumor. This review describes current state of research on the role of neutrophils in carcinogenesis, as well as possible approaches of using these cells and their derivatives as systems for targeted delivery of therapeutic drugs for treatment of malignant neoplasms. |
| Author | Rakitina, Aleksandra S. Vasiukova, Anastasiia A. Garanina, Anastasiia S. Gabashvili, Anna N. |
| Author_xml | – sequence: 1 givenname: Anna N. surname: Gabashvili fullname: Gabashvili, Anna N. organization: Prokhorov General Physics Institute, Russian Academy of Sciences, Koltzov Institute of Developmental Biology, Russian Academy of Sciences – sequence: 2 givenname: Anastasiia A. surname: Vasiukova fullname: Vasiukova, Anastasiia A. organization: Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation – sequence: 3 givenname: Aleksandra S. surname: Rakitina fullname: Rakitina, Aleksandra S. organization: Prokhorov General Physics Institute, Russian Academy of Sciences, Moscow Institute of Physics and Technology – sequence: 4 givenname: Anastasiia S. surname: Garanina fullname: Garanina, Anastasiia S. email: anastasiacit@gmail.com organization: National University of Science and Technology “MISIS” |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40367075$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kU1P3DAQhq0KVBbaH9ALssSFS4q_4iRHtC0UiS-1i9Rb5DiTxSixF08iwb_H0dJWKuI0mpnnfcee2Sc7Pngg5AtnXzmX6uQXY0yLqqiE0kzq8vcHsuCalZlkiu2QxdzO5v4e2Ud8SKlglfxI9lSiC1bkC_K0ugd6gTgBDZ5-m0zvcHSW_gx9qnT0GqYxhs2965E6T5cmWufDGjygQ2p8S5OBi_Q2ILomae4QaBciXUUw4wB-nF2uku3am5RcQ9j0Bgf8RHY70yN8fo0H5O7s-2r5I7u8Ob9Ynl5mVgo9ZqJQYCrdat3pwnalbgppbW47w1owOa-saisj089syazVLS8VE1yVhje5abQ8IMdb300MjxPgWA8OLfS98RAmrKVgSoqC5yqhR_-hD2GKPr1upmQu8kqIRB2-UlMzQFtvohtMfK7_7DQBfAvYmJYSofuLcFbPd6vf3C1pxFaDifVriP9Gvy96ATxLmPg |
| Cites_doi | 10.1038/s41467-023-37515-8 10.1002/adhm.201500998 10.1074/mcp.M500143-MCP200 10.1172/JCI130952 10.1016/j.it.2019.04.010 10.1038/bjc.2013.167 10.1007/s00262-013-1476-9 10.1039/C9MH01068H 10.1172/JCI41649 10.1016/j.apsb.2018.12.009 10.1186/s12943-018-0898-6 10.1111/imr.13176 10.1038/nature15367 10.1002/adma.201701021 10.15252/embj.201490147 10.1016/j.ijpharm.2018.06.021 10.1002/adma.201901179 10.18632/oncotarget.18771 10.1038/ni.2194 10.1172/JCI68189 10.1016/s1074-7613(00)80504-x 10.4049/jimmunol.180.8.5575 10.1002/smll.201804191 10.1002/ijc.27572 10.1186/s40425-019-0706-x 10.1002/ijc.29945 10.1007/s00441-017-2731-8 10.1172/JCI61067 10.1016/j.actbio.2020.01.011 10.1002/ijc.29444 10.1038/nature11465 10.1016/j.ccr.2009.06.017 10.1186/ar3534 10.1016/j.cell.2013.04.040 10.1172/JCI37223 10.1016/j.cell.2019.05.047 10.1080/2162402X.2016.1232221 10.3389/fimmu.2019.02603 10.1189/jlb.1212619 10.1371/journal.ppat.1004651 10.1189/jlb.1211639 10.1038/s41586-019-0915-y 10.1016/j.it.2012.05.007 10.1084/jem.20130440 10.1186/s12951-021-00922-4 10.1172/JCI77053 10.1189/jlb.0311123 10.1038/nature14407 10.1182/blood.V84.6.1737.1737 10.1016/j.immuni.2017.09.012 10.1016/j.ccell.2017.12.012 10.1038/s41467-020-14963-0 10.1053/j.gastro.2016.02.040 10.1126/science.aao4227 10.1016/j.ccell.2015.11.005 10.1158/1541-7786.MCR-18-0638 10.1038/s41389-020-00267-x 10.1016/j.ccell.2016.06.001 10.18632/oncotarget.7969 10.3389/fimmu.2021.602963 10.1038/s41467-020-20733-9 10.1021/acsnano.3c02013 10.1136/jitc-2020-002068 10.1038/nri3024 10.1002/adhm.201700818 10.1136/jitc-2022-005798 10.1002/ijc.31808 10.1038/nnano.2017.54 10.1016/j.biomaterials.2021.120784 10.1111/cas.13286 10.1038/s41577-019-0141-8 10.1053/j.gastro.2018.12.003 10.1016/j.smim.2017.12.004 10.4049/jimmunol.180.10.6439 10.1158/2159-8290.CD-15-1157 10.20892/j.issn.2095-3941.2019.0353 10.1021/acsnano.9b03848 10.1073/pnas.1905054116 10.1039/c9bm01732a 10.1016/j.celrep.2014.12.039 10.1016/j.ccr.2011.08.012 10.1007/s00441-017-2763-0 10.1038/s41467-021-23731-7 10.21873/anticanres.13197 10.1161/CIRCRESAHA.114.301374 10.1073/pnas.1424927112 10.1038/ni.2526 10.1038/nm.3291 10.1158/2159-8290.CD-20-1808 10.1152/physrev.00012.2018 10.1021/acsnano.7b03190 10.1038/s41556-020-0491-2 10.1073/pnas.1907660116 10.1186/s12951-020-00682-7 10.1186/1477-5956-5-12 10.1016/j.ymthe.2019.09.019 10.1084/jem.20181468 10.3390/ijms22020821 10.1002/art.1780291105 10.1016/j.celrep.2017.11.052 10.1080/0284186X.2017.1348623 10.1016/j.cell.2018.12.040 10.1039/c9bm01278h 10.1016/j.cell.2021.04.016 10.1126/sciimmunol.aat4579 10.7150/thno.49577 10.1371/journal.pone.0153567 10.1084/jem.20181170 10.1038/nature13111 10.1038/s41467-018-03080-8 10.1073/pnas.1901562116 10.1371/journal.pone.0085696 10.1016/j.immuni.2019.11.001 10.1038/cmi.2014.37 10.1016/j.ccell.2016.06.021 10.3390/ijms20112767 10.1158/0008-5472.CAN-19-1972 10.1172/JCI164918 10.1016/j.ccell.2023.01.002 10.1038/s41571-019-0222-4 10.1126/scitranslmed.abb5817 10.1146/annurev-micro-102215-095513 10.1111/eci.12967 10.1021/acsnano.6b06477 10.1111/j.1365-2613.2009.00641.x 10.1038/s41565-018-0254-4 10.1038/s41416-018-0198-3 10.1158/0008-5472.can-03-1808 |
| ContentType | Journal Article |
| Copyright | Pleiades Publishing, Ltd. 2025 Copyright Springer Nature B.V. Mar 2025 |
| Copyright_xml | – notice: Pleiades Publishing, Ltd. 2025 – notice: Copyright Springer Nature B.V. Mar 2025 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7TM 7U9 C1K H94 K9. M7N 7X8 |
| DOI | 10.1134/S000629792460368X |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Nucleic Acids Abstracts Virology and AIDS Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | Virology and AIDS Abstracts MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology Chemistry Biology |
| EISSN | 1608-3040 |
| EndPage | 320 |
| ExternalDocumentID | 40367075 10_1134_S000629792460368X |
| Genre | Journal Article Review |
| GroupedDBID | -Y2 -~X .86 .VR 06C 06D 0R~ 0VY 1N0 23N 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 4.4 408 409 40D 40E 5GY 5VS 67N 67Z 6J9 6NX 78A 7X7 88E 88I 8AO 8C1 8CJ 8FE 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X A8Z AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDBE ABDBF ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFO ACGFS ACGOD ACHSB ACHXU ACKNC ACMDZ ACMFV ACMLO ACOKC ACOMO ACPIV ACPRK ACREN ACUHS ACZOJ ADBBV ADHHG ADHIR ADHKG ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AETLH AEUYN AEVLU AEXYK AFDZB AFFNX AFGCZ AFKRA AFLOW AFOHR AFQWF AFRAH AFWTZ AFYQB AFZKB AGAYW AGDGC AGJBK AGMZJ AGQMX AGQPQ AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHPBZ AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG ATHPR AVWKF AXYYD AZFZN AZQEC B-. B0M BA0 BBNVY BDATZ BENPR BGNMA BHPHI BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP D1J DDRTE DL5 DNIVK DPUIP DU5 DWQXO EAD EAP EBD EBLON EBS EIOEI EJD EMB EMK EMOBN EN4 EPL ESBYG ESX F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ7 GQ8 GX1 GXS H13 HCIFZ HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ H~9 IAO IEA IHE IHR IJ- IKXTQ INH INR ITC ITM IWAJR IXC IZIGR I~X I~Z J-C JBSCW JCJTX JZLTJ KDC KOV KPH LAK LK8 LLZTM M1P M2P M4Y M7P MA- N2Q NB0 NPVJJ NQJWS NU0 O9- O93 O9I O9J OAM OVD P2P PF0 PHGZM PHGZT PQQKQ PROAC PSQYO PT4 Q2X QOR QOS R89 R9I RNI RNS ROL RPX RSV RZC RZE S16 S1Z S27 S3A S3B SAP SBL SDH SHX SISQX SJN SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW STPWE SV3 SZN T13 TEORI TSG TSK TSV TUC TUS U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WJK WK8 YLTOR ZGI ZMTXR ZOVNA ~8M ~A9 ~KM AAYXX ABFSG ACSTC AEZWR AFHIU AHWEU AIXLP CITATION ABRTQ CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 7QL 7TM 7U9 C1K H94 K9. M7N 7X8 |
| ID | FETCH-LOGICAL-c326t-274ea96d66f67cf86b73cc5cfa0dea519c4d9a3002c80cc6d18402148a1b5ab63 |
| IEDL.DBID | U2A |
| ISSN | 0006-2979 1608-3040 |
| IngestDate | Fri Jul 11 17:47:38 EDT 2025 Fri Jul 25 10:42:08 EDT 2025 Mon Jul 21 06:02:54 EDT 2025 Tue Jul 01 04:57:24 EDT 2025 Thu May 08 05:26:52 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | targeted delivery carcinogenesis neutrophils tumor therapy |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c326t-274ea96d66f67cf86b73cc5cfa0dea519c4d9a3002c80cc6d18402148a1b5ab63 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| PMID | 40367075 |
| PQID | 3203525922 |
| PQPubID | 54009 |
| PageCount | 18 |
| ParticipantIDs | proquest_miscellaneous_3204327154 proquest_journals_3203525922 pubmed_primary_40367075 crossref_primary_10_1134_S000629792460368X springer_journals_10_1134_S000629792460368X |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20250300 2025-03-00 2025-Mar 20250301 |
| PublicationDateYYYYMMDD | 2025-03-01 |
| PublicationDate_xml | – month: 3 year: 2025 text: 20250300 |
| PublicationDecade | 2020 |
| PublicationPlace | Moscow |
| PublicationPlace_xml | – name: Moscow – name: United States – name: New York |
| PublicationTitle | Biochemistry (Moscow) |
| PublicationTitleAbbrev | Biochemistry Moscow |
| PublicationTitleAlternate | Biochemistry (Mosc) |
| PublicationYear | 2025 |
| Publisher | Pleiades Publishing Springer Nature B.V |
| Publisher_xml | – name: Pleiades Publishing – name: Springer Nature B.V |
| References | A. Spiegel (2836_CR89) 2016; 6 J. M. Adrover (2836_CR31) 2019; 51 V. Naumenko (2836_CR117) 2020; 104 E. Hacbarth (2836_CR14) 1986; 29 L. G. Ng (2836_CR24) 2019; 19 F. Liu (2836_CR27) 1996; 5 C. A. Fromen (2836_CR116) 2017; 11 M. Casanova-Acebes (2836_CR29) 2013; 153 E. Pylaeva (2836_CR103) 2019; 144 D. Melisi (2836_CR128) 2021; 9 Q. Chen (2836_CR74) 2022; 10 L. Raccosta (2836_CR82) 2013; 210 L. Bejarano (2836_CR22) 2021; 11 Y. Koga (2836_CR47) 2004; 64 A. Ui Mhaonaigh (2836_CR16) 2019; 10 G. Lominadze (2836_CR39) 2005; 4 Y. Liu (2836_CR97) 2016; 30 D. Triner (2836_CR56) 2019; 156 Q. Zhang (2836_CR122) 2018; 13 R. Morimoto-Kamata (2836_CR94) 2017; 108 T. Jamieson (2836_CR80) 2012; 122 Z. Granot (2836_CR50) 2011; 20 M. Massara (2836_CR49) 2018; 9 C. Giallongo (2836_CR19) 2016; 7 A. Viola (2836_CR81) 2012; 33 M. Ostafin (2836_CR87) 2021; 22 K. L. Vogt (2836_CR37) 2018; 48 C. Zhang (2836_CR125) 2019; 31 I. Puga (2836_CR33) 2011; 13 M. E. Shaul (2836_CR68) 2016; 5 Z. G. Fridlender (2836_CR61) 2009; 16 N. Glodde (2836_CR70) 2017; 47 C. Yin (2836_CR41) 2018; 371 L. Andzinski (2836_CR69) 2016; 138 M. Perego (2836_CR101) 2020; 12 K. J. Eash (2836_CR28) 2010; 120 A. Margraf (2836_CR108) 2019; 40 B. Ye (2836_CR113) 2020; 18 Y. Deng (2836_CR17) 2016; 11 I. L. Linde (2836_CR106) 2023; 41 M. Li (2836_CR119) 2020; 11 C. A. Brennan (2836_CR55) 2016; 70 A. Mantovani (2836_CR35) 2011; 11 W. Lee (2836_CR98) 2019; 216 X. Cao (2836_CR123) 2019; 9 A. Watanabe (2836_CR100) 2019; 39 E. B. Eruslanov (2836_CR52) 2014; 124 N. Hu (2836_CR79) 2011; 13 M. Bilusic (2836_CR127) 2019; 7 J. Faget (2836_CR6) 2017; 21 S. Singhal (2836_CR51) 2016; 30 B. B. Antuamwine (2836_CR75) 2023; 314 Z. Wang (2836_CR90) 2020; 9 Z. Li (2836_CR59) 2012; 131 X. Zhang (2836_CR92) 2018; 17 J. Nishida (2836_CR5) 2020; 22 M. Casanova-Acebes (2836_CR34) 2018; 215 Y. Zhang (2836_CR104) 2020; 28 D. H. McDermott (2836_CR126) 2023; 133 C. Jin (2836_CR57) 2019; 176 D. Chu (2836_CR120) 2016; 5 E. McKenna (2836_CR23) 2021; 12 Y. Liu (2836_CR15) 2017; 8 C. Li (2836_CR114) 2020; 8 D. Jethwaney (2836_CR43) 2007; 5 A. Ponzetta (2836_CR53) 2019; 178 J. Jablonska (2836_CR64) 2010; 120 S. M. Uriarte (2836_CR42) 2008; 180 F. S. Lakschevitz (2836_CR32) 2015; 12 A. Carus (2836_CR99) 2013; 108 A. J. Wisdom (2836_CR105) 2019; 116 V. Naumenko (2836_CR3) 2018; 371 P. Kruger (2836_CR8) 2015; 11 T. Kang (2836_CR12) 2017; 11 A. Ssemaganda (2836_CR18) 2014; 9 S. V. Novitskiy (2836_CR67) 2012; 92 S. L. Zhou (2836_CR88) 2016; 150 I. Lerman (2836_CR86) 2019; 17 L. M. Schiffmann (2836_CR78) 2019; 120 S. Tazzyman (2836_CR83) 2009; 90 S. Rorvig (2836_CR40) 2013; 94 T. Bald (2836_CR91) 2014; 507 Q. Wang (2836_CR7) 2018; 33 A. Schernberg (2836_CR76) 2017; 56 A. Tyagi (2836_CR73) 2021; 12 V. A. Naumenko (2836_CR118) 2019; 13 H. Dong (2836_CR112) 2019; 7 Y. Hao (2836_CR58) 2019; 20 V. Finisguerra (2836_CR46) 2015; 522 J. Y. Chung (2836_CR102) 2023; 14 J. Wang (2836_CR13) 2021; 273 S. I. Grivennikov (2836_CR54) 2012; 491 Y. Su (2836_CR111) 2023; 17 H. Mora-Jensen (2836_CR38) 2011; 90 C. F. Wu (2836_CR65) 2015; 137 A. J. Casbon (2836_CR63) 2015; 112 J. I. Youn (2836_CR62) 2013; 14 A. Blaisdell (2836_CR45) 2015; 28 C. Ju (2836_CR110) 2019; 15 J. Zhou (2836_CR20) 2018; 35 A. S. Chung (2836_CR77) 2013; 19 G. J. Lieschke (2836_CR26) 1994; 84 J. D. Waight (2836_CR60) 2013; 123 D. Zhang (2836_CR30) 2015; 525 Y. Shi (2836_CR10) 2020; 10 K. Mahiddine (2836_CR44) 2020; 130 I. Mishalian (2836_CR66) 2013; 62 N. Antonio (2836_CR84) 2015; 34 J. Xue (2836_CR109) 2017; 12 X. Luo (2836_CR115) 2018; 547 J. Y. Sagiv (2836_CR21) 2015; 10 J. Albrengues (2836_CR96) 2018; 361 Y. Su (2836_CR121) 2020; 7 B. M. Szczerba (2836_CR93) 2019; 566 M. Saini (2836_CR95) 2019; 79 L. S. C. Lok (2836_CR36) 2019; 116 C. Cui (2836_CR124) 2021; 184 K. Ley (2836_CR1) 2018; 3 C. Zha (2836_CR85) 2020; 17 D. Chu (2836_CR9) 2017; 29 S. R. Nielsen (2836_CR71) 2021; 12 Q. Zhao (2836_CR11) 2021; 19 C. Hagerling (2836_CR48) 2019; 116 P. X. Liew (2836_CR25) 2019; 99 B. Petri (2836_CR2) 2008; 180 M. E. Shaul (2836_CR4) 2019; 16 S. Nadkarni (2836_CR72) 2014; 114 A. S. Timin (2836_CR107) 2018; 7 |
| References_xml | – volume: 14 year: 2023 ident: 2836_CR102 publication-title: Nat. Commun. doi: 10.1038/s41467-023-37515-8 – volume: 5 start-page: 1088 year: 2016 ident: 2836_CR120 publication-title: Adv. Healthc. Mater. doi: 10.1002/adhm.201500998 – volume: 4 start-page: 1503 year: 2005 ident: 2836_CR39 publication-title: Mol. Cell Proteomics doi: 10.1074/mcp.M500143-MCP200 – volume: 130 start-page: 389 year: 2020 ident: 2836_CR44 publication-title: J. Clin. Invest. doi: 10.1172/JCI130952 – volume: 40 start-page: 613 year: 2019 ident: 2836_CR108 publication-title: Trends Immunol. doi: 10.1016/j.it.2019.04.010 – volume: 108 start-page: 2116 year: 2013 ident: 2836_CR99 publication-title: Br. J. Cancer doi: 10.1038/bjc.2013.167 – volume: 62 start-page: 1745 year: 2013 ident: 2836_CR66 publication-title: Cancer Immunol. Immunother. doi: 10.1007/s00262-013-1476-9 – volume: 7 start-page: 574 year: 2020 ident: 2836_CR121 publication-title: Materials Horizons doi: 10.1039/C9MH01068H – volume: 120 start-page: 2423 year: 2010 ident: 2836_CR28 publication-title: J. Clin. Invest. doi: 10.1172/JCI41649 – volume: 9 start-page: 575 year: 2019 ident: 2836_CR123 publication-title: Acta Pharm. Sin. B doi: 10.1016/j.apsb.2018.12.009 – volume: 17 year: 2018 ident: 2836_CR92 publication-title: Mol. Cancer doi: 10.1186/s12943-018-0898-6 – volume: 314 start-page: 250 year: 2023 ident: 2836_CR75 publication-title: Immunol. Rev. doi: 10.1111/imr.13176 – volume: 525 start-page: 528 year: 2015 ident: 2836_CR30 publication-title: Nature doi: 10.1038/nature15367 – volume: 29 year: 2017 ident: 2836_CR9 publication-title: Adv. Mater. doi: 10.1002/adma.201701021 – volume: 34 start-page: 2219 year: 2015 ident: 2836_CR84 publication-title: EMBO J. doi: 10.15252/embj.201490147 – volume: 547 start-page: 315 year: 2018 ident: 2836_CR115 publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2018.06.021 – volume: 31 year: 2019 ident: 2836_CR125 publication-title: Adv. Mater. doi: 10.1002/adma.201901179 – volume: 8 start-page: 90969 year: 2017 ident: 2836_CR15 publication-title: Oncotarget doi: 10.18632/oncotarget.18771 – volume: 13 start-page: 170 year: 2011 ident: 2836_CR33 publication-title: Nat. Immunol. doi: 10.1038/ni.2194 – volume: 123 start-page: 4464 year: 2013 ident: 2836_CR60 publication-title: J. Clin. Invest. doi: 10.1172/JCI68189 – volume: 5 start-page: 491 year: 1996 ident: 2836_CR27 publication-title: Immunity doi: 10.1016/s1074-7613(00)80504-x – volume: 180 start-page: 5575 year: 2008 ident: 2836_CR42 publication-title: J. Immunol. doi: 10.4049/jimmunol.180.8.5575 – volume: 15 year: 2019 ident: 2836_CR110 publication-title: Small doi: 10.1002/smll.201804191 – volume: 131 start-page: 2584 year: 2012 ident: 2836_CR59 publication-title: Int. J. Cancer doi: 10.1002/ijc.27572 – volume: 7 year: 2019 ident: 2836_CR127 publication-title: J. Immunother. Cancer doi: 10.1186/s40425-019-0706-x – volume: 138 start-page: 1982 year: 2016 ident: 2836_CR69 publication-title: Int. J. Cancer doi: 10.1002/ijc.29945 – volume: 371 start-page: 455 year: 2018 ident: 2836_CR41 publication-title: Cell Tissue Res. doi: 10.1007/s00441-017-2731-8 – volume: 122 start-page: 3127 year: 2012 ident: 2836_CR80 publication-title: J. Clin. Invest. doi: 10.1172/JCI61067 – volume: 104 start-page: 176 year: 2020 ident: 2836_CR117 publication-title: Acta Biomater. doi: 10.1016/j.actbio.2020.01.011 – volume: 137 start-page: 837 year: 2015 ident: 2836_CR65 publication-title: Int. J. Cancer doi: 10.1002/ijc.29444 – volume: 491 start-page: 254 year: 2012 ident: 2836_CR54 publication-title: Nature doi: 10.1038/nature11465 – volume: 16 start-page: 183 year: 2009 ident: 2836_CR61 publication-title: Cancer Cell doi: 10.1016/j.ccr.2009.06.017 – volume: 13 year: 2011 ident: 2836_CR79 publication-title: Arthritis Res. Ther. doi: 10.1186/ar3534 – volume: 153 start-page: 1025 year: 2013 ident: 2836_CR29 publication-title: Cell doi: 10.1016/j.cell.2013.04.040 – volume: 120 start-page: 1151 year: 2010 ident: 2836_CR64 publication-title: J. Clin. Invest. doi: 10.1172/JCI37223 – volume: 178 start-page: 346 year: 2019 ident: 2836_CR53 publication-title: Cell doi: 10.1016/j.cell.2019.05.047 – volume: 5 year: 2016 ident: 2836_CR68 publication-title: Oncoimmunology doi: 10.1080/2162402X.2016.1232221 – volume: 10 year: 2019 ident: 2836_CR16 publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.02603 – volume: 94 start-page: 711 year: 2013 ident: 2836_CR40 publication-title: J. Leukoc. Bio. doi: 10.1189/jlb.1212619 – volume: 11 year: 2015 ident: 2836_CR8 publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1004651 – volume: 92 start-page: 641 year: 2012 ident: 2836_CR67 publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.1211639 – volume: 566 start-page: 553 year: 2019 ident: 2836_CR93 publication-title: Nature doi: 10.1038/s41586-019-0915-y – volume: 33 start-page: 496 year: 2012 ident: 2836_CR81 publication-title: Trends Immunol. doi: 10.1016/j.it.2012.05.007 – volume: 210 start-page: 1711 year: 2013 ident: 2836_CR82 publication-title: J. Exp. Med. doi: 10.1084/jem.20130440 – volume: 19 year: 2021 ident: 2836_CR11 publication-title: J. Nanobiotechnol. doi: 10.1186/s12951-021-00922-4 – volume: 124 start-page: 5466 year: 2014 ident: 2836_CR52 publication-title: J. Clin. Invest. doi: 10.1172/JCI77053 – volume: 90 start-page: 629 year: 2011 ident: 2836_CR38 publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.0311123 – volume: 522 start-page: 349 year: 2015 ident: 2836_CR46 publication-title: Nature doi: 10.1038/nature14407 – volume: 84 start-page: 1737 year: 1994 ident: 2836_CR26 publication-title: Blood doi: 10.1182/blood.V84.6.1737.1737 – volume: 47 start-page: 789 year: 2017 ident: 2836_CR70 publication-title: Immunity doi: 10.1016/j.immuni.2017.09.012 – volume: 33 year: 2018 ident: 2836_CR7 publication-title: Cancer Cell doi: 10.1016/j.ccell.2017.12.012 – volume: 11 year: 2020 ident: 2836_CR119 publication-title: Nat. Commun. doi: 10.1038/s41467-020-14963-0 – volume: 150 start-page: 1646 year: 2016 ident: 2836_CR88 publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.02.040 – volume: 361 year: 2018 ident: 2836_CR96 publication-title: Science doi: 10.1126/science.aao4227 – volume: 28 start-page: 785 year: 2015 ident: 2836_CR45 publication-title: Cancer Cell doi: 10.1016/j.ccell.2015.11.005 – volume: 17 start-page: 845 year: 2019 ident: 2836_CR86 publication-title: Mol. Cancer Res. doi: 10.1158/1541-7786.MCR-18-0638 – volume: 9 year: 2020 ident: 2836_CR90 publication-title: Oncogenesis doi: 10.1038/s41389-020-00267-x – volume: 30 start-page: 120 year: 2016 ident: 2836_CR51 publication-title: Cancer Cell doi: 10.1016/j.ccell.2016.06.001 – volume: 7 start-page: 85764 year: 2016 ident: 2836_CR19 publication-title: Oncotarget doi: 10.18632/oncotarget.7969 – volume: 12 year: 2021 ident: 2836_CR23 publication-title: Front. Immunol. doi: 10.3389/fimmu.2021.602963 – volume: 12 year: 2021 ident: 2836_CR73 publication-title: Nat. Commun. doi: 10.1038/s41467-020-20733-9 – volume: 17 start-page: 15542 year: 2023 ident: 2836_CR111 publication-title: ACS Nano doi: 10.1021/acsnano.3c02013 – volume: 9 year: 2021 ident: 2836_CR128 publication-title: J. Immunother. Cancer doi: 10.1136/jitc-2020-002068 – volume: 11 start-page: 519 year: 2011 ident: 2836_CR35 publication-title: Nat. Rev. Immunol. doi: 10.1038/nri3024 – volume: 7 year: 2018 ident: 2836_CR107 publication-title: Adv. Healthc. Mater. doi: 10.1002/adhm.201700818 – volume: 10 year: 2022 ident: 2836_CR74 publication-title: J. Immunother. Cancer doi: 10.1136/jitc-2022-005798 – volume: 144 start-page: 136 year: 2019 ident: 2836_CR103 publication-title: Int. J. Cancer doi: 10.1002/ijc.31808 – volume: 12 start-page: 692 year: 2017 ident: 2836_CR109 publication-title: Nat. Nanotechnol. doi: 10.1038/nnano.2017.54 – volume: 273 year: 2021 ident: 2836_CR13 publication-title: Biomaterials doi: 10.1016/j.biomaterials.2021.120784 – volume: 108 start-page: 1574 year: 2017 ident: 2836_CR94 publication-title: Cancer Sci. doi: 10.1111/cas.13286 – volume: 19 start-page: 255 year: 2019 ident: 2836_CR24 publication-title: Nat. Rev. Immunol. doi: 10.1038/s41577-019-0141-8 – volume: 156 start-page: 1467 year: 2019 ident: 2836_CR56 publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.12.003 – volume: 35 start-page: 19 year: 2018 ident: 2836_CR20 publication-title: Semin. Immunol. doi: 10.1016/j.smim.2017.12.004 – volume: 180 start-page: 6439 year: 2008 ident: 2836_CR2 publication-title: J. Immunol. doi: 10.4049/jimmunol.180.10.6439 – volume: 6 start-page: 630 year: 2016 ident: 2836_CR89 publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-15-1157 – volume: 17 start-page: 154 year: 2020 ident: 2836_CR85 publication-title: Cancer Biol. Med. doi: 10.20892/j.issn.2095-3941.2019.0353 – volume: 13 start-page: 12599 year: 2019 ident: 2836_CR118 publication-title: ACS Nano doi: 10.1021/acsnano.9b03848 – volume: 116 start-page: 19083 year: 2019 ident: 2836_CR36 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1905054116 – volume: 8 start-page: 2189 year: 2020 ident: 2836_CR114 publication-title: Biomater. Sci. doi: 10.1039/c9bm01732a – volume: 10 start-page: 562 year: 2015 ident: 2836_CR21 publication-title: Cell Rep. doi: 10.1016/j.celrep.2014.12.039 – volume: 20 start-page: 300 year: 2011 ident: 2836_CR50 publication-title: Cancer Cell doi: 10.1016/j.ccr.2011.08.012 – volume: 371 start-page: 505 year: 2018 ident: 2836_CR3 publication-title: Cell Tissue Res. doi: 10.1007/s00441-017-2763-0 – volume: 12 year: 2021 ident: 2836_CR71 publication-title: Nat. Commun. doi: 10.1038/s41467-021-23731-7 – volume: 39 start-page: 941 year: 2019 ident: 2836_CR100 publication-title: Anticancer Res. doi: 10.21873/anticanres.13197 – volume: 114 start-page: 242 year: 2014 ident: 2836_CR72 publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.114.301374 – volume: 112 start-page: E566 year: 2015 ident: 2836_CR63 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1424927112 – volume: 14 start-page: 211 year: 2013 ident: 2836_CR62 publication-title: Nat. Immunol. doi: 10.1038/ni.2526 – volume: 19 start-page: 1114 year: 2013 ident: 2836_CR77 publication-title: Nat. Med. doi: 10.1038/nm.3291 – volume: 11 start-page: 933 year: 2021 ident: 2836_CR22 publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-20-1808 – volume: 99 start-page: 1223 year: 2019 ident: 2836_CR25 publication-title: Physiol. Rev. doi: 10.1152/physrev.00012.2018 – volume: 11 start-page: 10797 year: 2017 ident: 2836_CR116 publication-title: ACS Nano doi: 10.1021/acsnano.7b03190 – volume: 22 start-page: 465 year: 2020 ident: 2836_CR5 publication-title: Nat. Cell Biol. doi: 10.1038/s41556-020-0491-2 – volume: 116 start-page: 21704 year: 2019 ident: 2836_CR48 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1907660116 – volume: 18 year: 2020 ident: 2836_CR113 publication-title: J. Nanobiotechnol. doi: 10.1186/s12951-020-00682-7 – volume: 5 year: 2007 ident: 2836_CR43 publication-title: Proteome Sci. doi: 10.1186/1477-5956-5-12 – volume: 28 start-page: 89 year: 2020 ident: 2836_CR104 publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2019.09.019 – volume: 215 start-page: 2778 year: 2018 ident: 2836_CR34 publication-title: J. Exp. Med. doi: 10.1084/jem.20181468 – volume: 22 year: 2021 ident: 2836_CR87 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms22020821 – volume: 29 start-page: 1334 year: 1986 ident: 2836_CR14 publication-title: Arthritis Rheum. doi: 10.1002/art.1780291105 – volume: 21 start-page: 3190 year: 2017 ident: 2836_CR6 publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.11.052 – volume: 56 start-page: 1522 year: 2017 ident: 2836_CR76 publication-title: Acta Oncol. doi: 10.1080/0284186X.2017.1348623 – volume: 176 start-page: 998 year: 2019 ident: 2836_CR57 publication-title: Cell doi: 10.1016/j.cell.2018.12.040 – volume: 7 start-page: 5238 year: 2019 ident: 2836_CR112 publication-title: Biomater. Sci. doi: 10.1039/c9bm01278h – volume: 184 start-page: 3163 year: 2021 ident: 2836_CR124 publication-title: Cell doi: 10.1016/j.cell.2021.04.016 – volume: 3 year: 2018 ident: 2836_CR1 publication-title: Sci. Immunol. doi: 10.1126/sciimmunol.aat4579 – volume: 10 start-page: 7921 year: 2020 ident: 2836_CR10 publication-title: Theranostics doi: 10.7150/thno.49577 – volume: 11 year: 2016 ident: 2836_CR17 publication-title: PLoS One doi: 10.1371/journal.pone.0153567 – volume: 216 start-page: 176 year: 2019 ident: 2836_CR98 publication-title: J. Exp. Med. doi: 10.1084/jem.20181170 – volume: 507 start-page: 109 year: 2014 ident: 2836_CR91 publication-title: Nature doi: 10.1038/nature13111 – volume: 9 year: 2018 ident: 2836_CR49 publication-title: Nat. Commun. doi: 10.1038/s41467-018-03080-8 – volume: 116 start-page: 18584 year: 2019 ident: 2836_CR105 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1901562116 – volume: 9 year: 2014 ident: 2836_CR18 publication-title: PLoS One doi: 10.1371/journal.pone.0085696 – volume: 51 start-page: 966 year: 2019 ident: 2836_CR31 publication-title: Immunity doi: 10.1016/j.immuni.2019.11.001 – volume: 12 start-page: 53 year: 2015 ident: 2836_CR32 publication-title: Cell Mol. Immunol. doi: 10.1038/cmi.2014.37 – volume: 30 start-page: 243 year: 2016 ident: 2836_CR97 publication-title: Cancer Cell doi: 10.1016/j.ccell.2016.06.021 – volume: 20 year: 2019 ident: 2836_CR58 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms20112767 – volume: 79 start-page: 6067 year: 2019 ident: 2836_CR95 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-19-1972 – volume: 133 year: 2023 ident: 2836_CR126 publication-title: J. Clin. Invest. doi: 10.1172/JCI164918 – volume: 41 start-page: 356 year: 2023 ident: 2836_CR106 publication-title: Cancer Cell doi: 10.1016/j.ccell.2023.01.002 – volume: 16 start-page: 601 year: 2019 ident: 2836_CR4 publication-title: Nat. Rev. Clin. Oncol. doi: 10.1038/s41571-019-0222-4 – volume: 12 year: 2020 ident: 2836_CR101 publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.abb5817 – volume: 70 start-page: 395 year: 2016 ident: 2836_CR55 publication-title: Annu. Rev. Microbiol. doi: 10.1146/annurev-micro-102215-095513 – volume: 48 year: 2018 ident: 2836_CR37 publication-title: Eur. J. Clin. Invest. doi: 10.1111/eci.12967 – volume: 11 start-page: 1397 year: 2017 ident: 2836_CR12 publication-title: ACS Nano doi: 10.1021/acsnano.6b06477 – volume: 90 start-page: 222 year: 2009 ident: 2836_CR83 publication-title: Int. J. Exp. Pathol. doi: 10.1111/j.1365-2613.2009.00641.x – volume: 13 start-page: 1182 year: 2018 ident: 2836_CR122 publication-title: Nat. Nanotechnol. doi: 10.1038/s41565-018-0254-4 – volume: 120 start-page: 69 year: 2019 ident: 2836_CR78 publication-title: Br. J. Cancer doi: 10.1038/s41416-018-0198-3 – volume: 64 start-page: 1037 year: 2004 ident: 2836_CR47 publication-title: Cancer Res. doi: 10.1158/0008-5472.can-03-1808 |
| SSID | ssj0002093 |
| Score | 2.4101365 |
| SecondaryResourceType | review_article |
| Snippet | Neutrophils are phagocytic leukocytes of the myeloid series, which are the most common myeloid cells in human blood, normally accounting from 65 to 80% of all... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 303 |
| SubjectTerms | Animals Barriers Biochemistry Biomedical and Life Sciences Biomedicine Bioorganic Chemistry Carcinogenesis Carcinogenesis - immunology Carcinogenesis - pathology Carcinogens Drug delivery Drugs Functional plasticity Humans Immunosuppressive agents Leukocytes Leukocytes (neutrophilic) Life Sciences Macrophages Microbiology Myeloid cells Neoplasms Neoplasms - drug therapy Neoplasms - immunology Neoplasms - pathology Neoplasms - therapy Neutrophils Neutrophils - immunology Neutrophils - metabolism Neutrophils - pathology Phagocytes Review Tumor cells Tumors |
| Title | The Issue on Dualistic Role of Neutrophils in Carcinogenesis and Their Possible Use for Treatment of Malignant Neoplasms |
| URI | https://link.springer.com/article/10.1134/S000629792460368X https://www.ncbi.nlm.nih.gov/pubmed/40367075 https://www.proquest.com/docview/3203525922 https://www.proquest.com/docview/3204327154 |
| Volume | 90 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED_WlrG9jK7dh7c2aDD2sGFwZH1Yj1n6xUbLGAlkT0aS5TbQyqFOYPvvd1LsjJHuYW_GPp2NTjrdz_cF8L7gUmfCmNRwZlPGqEyN4iy1eSWdEzLXKiQnX16Jiyn7MuOzLo-77aPde5dk1NTrviMs5PRmgiqJgEGg2i1mO7DHEbqHZT2lo436pVlXaRehciDvXJkPsvj7MNqyMLe8o_HQOduHZ521SEZr8T6HR84fwOHII1K--0U-kBi_GX-MH8Djz_3Vk3Hfxe0QfuI6ILHFHmk8OQkplKEyM_ne3OKdmly51fK-WdzMb1sy92QcWgv55jpowHlLtK_IJLgSyLcmbB4cM20dQUOXTPoI9cDlEtleh5Aa5Ncs0CC_a1_A9Ox0Mr5Iu24LKBcqlinCU6eVqISohbR1IYzMreW21lnlNBp6llVK5zjBtsisFVXAhhTRlB4aro3IX8Kub7x7DYQbSmscGLKxmLWqoJZWyFgNTVYZqRL42E97uVgX1SgjGMlZuSWjBI56wZTd_mrLnMY6rorSBN5tHuPUBneH9q5ZRRqWU4k2YgKv1gLdvI1loXCd5Al86iX8h_k_P-XNf1G_hac0NAuOAWtHsLu8X7ljtGCWZgB7o_MfX08HsHM-Gw7i-v0NclvojA |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwED9BJzReBmyMBQYYCfEAypQ5jh0_lrJR2FohlErlKbIdZ1RsSbWkEvDXc85HERQe9hYl9sXx2ef75b4AXsaRUAHX2tcRMz5jVPhaRsw3YSas5SJU0gUnT6Z8PGMf59G8i-Ouem_33iTZSOq27ghzMb0Bp1IgYOAoduP5bdhiCMGjAWwN3385O1kLYBp0uXYRLLsOnTHzn0T-PI42dMwN-2hz7Jzeg6QfcOtt8u1oVesj8_OvXI43_KL7sNOpoWTYrpsHcMsWu7A3LBCCX_0gr0jjGNr8cd-FO2_7q-1RXx5uD77jAiNN7T5SFuSdi810KZ_J5_IS7-Rkalf1dbn8urisyKIgI1ezqCgvnGhdVEQVGUmcjYJ8Kt2uxD6zyhLUoEnSu747KhMke-F8dZBeuURN_6p6CLPTk2Q09rsyDshwymsfca9Vkmec51yYPOZahMZEJldBZhVqkIZlUoXINxMHxvDMgU6KME0d60hpHu7DoCgLewAk0pTm2NGFeTFjZEwNzZCwPNZBpoX04HXPzXTZZutIG5QTsnRjtj047Pmddhu3SkPaJIiVlHrwYv0Yp9bZUVRhy1XThoVUoPLpwaN2nazfxgKXEU9EHrzpef6b-H-H8vhGrZ_D9jiZnKfnH6ZnT-AudRWJG6-4QxjU1yv7FNWkWj_rtsUvfMAF8A |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwED_BELCXCTZgYQOMhHgARUsdx44fS0c1PlZNqJX6FtmOMyptTrWkEvz3nN2kaCp74C1KzpfIZ5_vl_sCeJdnQiVc61hnzMSMURFrmbHYpKWwlotUSZ-cfD7hZzP2dZ7Nuz6nTR_t3rsk1zkNvkqTa0-WZdX1IGE-vzfhVAoEDxxVcD6_Dw9QGw98TNeMDjeqmCZd1V2EzZ68c2v-k8Xtg2nL2tzylIYDaPwE9jrLkQzXon4K96zbh4OhQ9R8_Zu8JyGWM_wk34eHn_qrx6O-o9sB_MI1QUK7PVI7curTKX2VZvKjvsI7FZnYVXtTL38urhqycGTk2wy5-tJrw0VDlCvJ1LsVyEXtNxKOmTWWoNFLpn20uudyjmwvfXgN8quXaJxfN89gNv48HZ3FXecFlBHlbYxQ1SrJS84rLkyVcy1SYzJTqaS0Co0-w0qpUpxgkyfG8NLjRIrISg10pjRPn8OOq509BJJpSisc6DOzmDEyp4aWyFgOdFJqISP40E97sVwX2CgCMElZsSWjCI57wRTdXmuKlIaarpLSCN5uHuPUeteHcrZeBRqWUoH2YgQv1gLdvI0lvoidyCL42Ev4L_M7P-Xlf1G_gUcXp-Pi-5fJtyPYpb6HcIhjO4ad9mZlX6Fh0-rXYfH-AVXA7TY |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Issue+on+Dualistic+Role+of+Neutrophils+in+Carcinogenesis+and+Their+Possible+Use+for+Treatment+of+Malignant+Neoplasms&rft.jtitle=Biochemistry+%28Moscow%29&rft.date=2025-03-01&rft.pub=Springer+Nature+B.V&rft.issn=0006-2979&rft.eissn=1608-3040&rft.volume=90&rft.issue=3&rft.spage=303&rft.epage=320&rft_id=info:doi/10.1134%2FS000629792460368X&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-2979&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-2979&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-2979&client=summon |